Q1 2016 Holdings
Filed 2016-05-13 | 9 holdings | $104.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Trevena, Inc. | Common Stock | 89532E109 | $22.1K | 2,669,280 | 21.1% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $19.9K | 2,018,450 | 19.0% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $15.2K | 1,968,606 | 14.6% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $11.9K | 1,230,009 | 11.4% |
| Pulmatrix Inc. | Common Stock | 74584P103 | $10.6K | 3,607,996 | 10.1% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $8.9K | 3,287,529 | 8.5% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $7.2K | 1,827,992 | 6.9% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $4.5K | 2,473,186 | 4.3% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $4.4K | 2,018,253 | 4.2% |